| Pathophysiology of motor dysfunction in Parkinson's disease as the rationale for drug treatment and rehabilitation | 2,632 |
| Gastrointestinal dysfunctions in Parkinson's disease: symptoms and treatments | 2,529 |
| DBS Programming: an evolving approach for patients with Parkinson's disease | 1,700 |
| LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson disease | 1,568 |
| Living with Parkinson's, the emerging role of occupational therapy. | 1,273 |
| Progressive resistance exercise and Parkinson's disease: A review of potential mechanisms | 1,117 |
| Comparing the Mini-BESTest with the Berg Balance Scale to Evaluate Balance Disorders in Parkinson's Disease | 1,075 |
| N-Acetyl Cysteine Protects against Methamphetamine-induced Dopaminergic Neurodegeneration via Modulation of Redox Status and Autophagy in Dopaminergic cells | 1,070 |
| METHAMPHETAMINE AND PARKINSON´S DISEASE | 1,055 |
| DOPAMINE OXIDATION AND AUTOPHAGY | 978 |
